Why PMDD Is Not a Mood Disorder but a State of Nervous System Overload
Premenstrual Dysphoric Disorder is commonly described as a severe mood disorder. Many women are told they have depression, anxiety, or a hormonal imbalance that simply needs to be suppressed. Yet when we look carefully at both the research and lived experience, the picture is more complex.
PMDD is cyclical. Symptoms arise after ovulation, intensify in the luteal phase, and often resolve within days of menstruation beginning. For many women, there are two distinct halves of the month: one where they feel clear, capable, and stable, and another where everything feels amplified, fragile, or unmanageable.
If this were a primary mood disorder, why would it switch off so predictably?
Increasingly, the evidence suggests that PMDD is not a classic psychiatric illness. It is better understood as a state of nervous system overload triggered by normal hormonal fluctuations in susceptible individuals. That distinction changes everything about how we approach treatment.
What the Current Model Gets Right and Where It Falls Short
PMDD is formally classified under depressive disorders in the Diagnostic and Statistical Manual of Mental Disorders (DSM 5). The diagnostic criteria focus on emotional symptoms such as mood swings, irritability, anxiety, low mood, and loss of interest, alongside physical symptoms.
This classification has been important for validation. It acknowledges that PMDD is real and can be profoundly impairing. However, diagnosis is based on symptom patterns, not biological mechanisms.
A mood disorder model implies that something is fundamentally wrong with a woman’s emotional functioning. Yet PMDD presents differently from major depressive disorder:
Ovarian hormone levels are usually within normal range
Symptoms are tightly linked to the luteal phase
Symptoms remit rapidly with menstruation
Selective serotonin reuptake inhibitors can work at lower doses and with faster onset than in major depression
These features point towards a neurobiological sensitivity rather than a primary mood pathology.
The question shifts from “What is wrong with her mood?” to “How is her nervous system responding to hormonal change?”
The Hormone Sensitivity Model: Normal Hormones, Different Response
Research consistently shows that women with PMDD do not produce abnormal levels of oestrogen or progesterone. The issue is not excess hormones. It is altered sensitivity to them.
After ovulation, progesterone rises. It is metabolised into allopregnanolone, a neurosteroid that interacts with the GABA A receptor. GABA is the brain’s primary inhibitory neurotransmitter. It helps regulate calm, inhibition, and resilience to stress.
In most individuals, rising progesterone and allopregnanolone produce a stabilising effect. In women with PMDD, this same neurosteroid interaction can have the opposite outcome. Instead of calm, it may trigger anxiety, agitation, irritability, and emotional dysregulation.
Neuroimaging studies have demonstrated increased amygdala reactivity and altered GABAergic modulation during the luteal phase in women with PMDD. The amygdala is central to threat detection and emotional intensity. When it is more reactive, the world can feel more dangerous, more personal, more overwhelming.
This is not simply a mood shift. It is a change in how the brain processes stress and safety.
PMDD as Nervous System Overload
When I work with women experiencing PMDD, I often describe the luteal phase as a period of lowered stress tolerance.
The nervous system operates along a spectrum between regulation and defence. When regulated, we can tolerate frustration, navigate conflict, and maintain perspective. When dysregulated, the same circumstances can feel unbearable.
During the luteal phase in PMDD, several things may occur simultaneously:
Reduced GABA mediated inhibition
Increased amygdala activation
Heightened stress hormone responsiveness
Lower threshold for sympathetic nervous system activation
In practical terms, this can feel like living with the volume turned up too high. Minor disagreements feel catastrophic. Small disappointments trigger disproportionate despair. Rejection sensitivity intensifies. Thoughts may darken rapidly.
The mood symptoms are real. But they are emerging from a nervous system in overload.
Understanding this removes moral judgement. It replaces it with physiology.
The Role of Stress Sensitisation and Trauma
Another consistent finding in PMDD research is the association with higher rates of adverse childhood experiences and chronic stress exposure.
This does not mean trauma causes PMDD. Many women with PMDD do not have significant trauma histories. However, trauma sensitises the stress response system. It can alter hypothalamic pituitary adrenal axis function and increase baseline vigilance.
When a nervous system is already primed towards hyper vigilance, hormonal fluctuations can act as amplifiers.
The luteal phase becomes a kind of biological stress test. If the system is already operating near threshold, small internal shifts can push it into overload.
This is where trauma informed care becomes clinically relevant. If we only address hormones without addressing nervous system sensitisation, progress may be limited.
Why This Reframe Changes Treatment
If PMDD is conceptualised solely as a mood disorder, treatment often centres on suppression. Hormonal suppression or antidepressants may be offered as first line interventions. For some women, these are appropriate and helpful.
However, if we understand PMDD as nervous system overload, our strategy expands.
Nutritional Stabilisation
Blood sugar instability increases sympathetic activation. Regular meals, adequate protein, and fibre rich plant foods support steadier glucose and stress regulation.
Magnesium plays a critical role in GABA signalling and stress buffering. Many women with PMDD benefit from optimising magnesium intake.
Omega 3 fatty acids support neuronal membrane fluidity and anti inflammatory pathways. I typically recommend Ahiflower oil for its balanced omega profile and its role in supporting mood stability.
A plant rich, anti inflammatory dietary pattern may also reduce neuroinflammatory load, which is increasingly recognised in mood and stress disorders.
Targeted Herbal Medicine
Saffron has evidence supporting its use in depressive and premenstrual mood symptoms. It appears to modulate serotonergic pathways.
Vitex may support luteal phase hormonal regulation in some women, although individualisation is essential.
Kava, used appropriately and with screening, can provide short term GABAergic calming during acute anxiety.
Herbal medicine is not about masking symptoms. It is about supporting physiological regulation.
Nervous System Regulation
Sleep stabilisation is foundational. Circadian disruption exacerbates stress reactivity.
Breathing practices that enhance vagal tone can improve resilience.
Reducing overall stress load, where possible, lowers baseline activation so the luteal phase is less destabilising.
Trauma Informed Mind Body Therapies
For women with stress sensitisation or unresolved trauma, deeper work is often required.
Family Constellations can help address inherited and systemic stress patterns that continue to influence nervous system responses.
Rapid Core Healing works at the level of subconscious emotional imprinting, supporting recalibration of threat perception and stress responses.
These modalities are not mystical add ons. They align with our understanding that chronic stress imprints the nervous system and that safety must be restored at more than a cognitive level.
From Pathology to Regulation
When a woman believes she has a mood disorder, there is often shame. There may be fear of being unstable or broken.
When she understands that her nervous system is responding intensely to hormonal change, something softens.
PMDD is not weakness. It is not a character flaw. It is not evidence of emotional inadequacy.
It is a cyclical, biologically mediated state of stress sensitivity.
The goal, then, is not simply to silence symptoms. It is to reduce nervous system load, improve stress tolerance, support neurochemical balance, and address any underlying sensitisation.
In my clinical experience, when women shift from suppression to regulation, they often begin to feel not only relief in the luteal phase, but greater stability throughout the entire cycle.
PMDD is real. The neurobiology is measurable. But it is not merely a mood disorder.
It is a nervous system that needs support.
And with the right, integrated, evidence informed approach, that support can lead to meaningful, lasting change.
Camilla Brinkworth is a UK-trained naturopath specialising in PMDD and hormone-sensitive mood disorders. She combines evidence-based nutrition, plant-rich medicine, lifestyle therapy, and trauma-informed approaches including Family Constellations and Rapid Core Healing to support nervous system regulation and long-term emotional stability.